Cosmos Health (COSM) EBT Margin (2014 - 2026)
Cosmos Health's (COSM) quarterly EBT Margin came in at 32.06% in Q2 2026, down 1288.0% on a YoY basis from 2.7% in Q2 2025, and down 104.86% quarter-over-quarter from 15.65% in Q1 2026.
Powered by 
Analysis
Cosmos Health (COSM) EBT Margin (2014 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported EBT Margin for 12 consecutive years, with 32.06% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin fell 1288.0% year-over-year to 32.06%; the trailing twelve-month figure through Jun 2026 stood at 33.08% (down 518.0% YoY), and the FY2025 full-year result was 29.33%, up 40.0% from the prior year.
- EBT Margin eased to 32.06% in Q2 2026 per COSM's latest filing, from 15.65% in the prior quarter.
- Across five years, EBT Margin topped out at 106.1% in Q4 2022 and bottomed at 138.27% in Q2 2022.
- Historically, EBT Margin has averaged 27.15% across 5 years, with a median of 19.4% in 2024.
- The widest YoY moves for EBT Margin: up 13109 bps in 2023, down 19292 bps in 2023.
- Over 5 years, EBT Margin stood at 106.1% in 2022, then tumbled by 182 bps to 86.82% in 2023, then increased by 23 bps to 67.09% in 2024, then grew by 23 bps to 51.49% in 2025, then surged by 38 bps to 32.06% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 32.06%, 15.65%, and 51.49% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | -10.99% |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | -1.70% |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 6.85% |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 8.92% |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 12.20% |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -121.92% |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 13.94% |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 20.96% |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 11.27% |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | -32.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.06% |
| Mar 31, 2026 | -15.65% |
| Dec 31, 2025 | -51.49% |
| Sep 30, 2025 | -31.28% |
| Jun 30, 2025 | -19.18% |
| Mar 31, 2025 | -5.97% |
| Dec 31, 2024 | -67.09% |
| Sep 30, 2024 | -17.59% |
| Jun 30, 2024 | -19.62% |
| Mar 31, 2024 | -12.80% |
| Dec 31, 2023 | -86.82% |
| Sep 30, 2023 | -26.63% |
| Jun 30, 2023 | -7.19% |
| Mar 31, 2023 | -3.94% |
| Dec 31, 2022 | 106.10% |
| Sep 30, 2022 | -16.58% |
| Jun 30, 2022 | -138.27% |
| Mar 31, 2022 | -42.73% |
| Dec 31, 2021 | -8.82% |
| Sep 30, 2021 | -13.00% |